Rémy Cointreau (RMC) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
3 Feb, 2026Executive summary
Q3 organic sales grew 2.8% year-over-year, driven by strong U.S. and EMEA performance, while APAC and China faced ongoing challenges and negative calendar effects.
Nine-month sales reached €735.4 million, down 6.6% reported and 1.9% organic year-over-year, mainly due to a 4.7% negative currency impact from USD and RMB.
Growth in the U.S. and EMEA offset continued declines in APAC and China.
Transformation program launched with external consultants to identify value-creation levers for deployment in 2026-27.
Financial highlights
Q3 sales: €245.8m, down 3.3% reported but up 2.8% organic year-over-year; nine-month sales: €735.4m, down 6.6% reported and 1.9% organic.
Cognac nine-month organic sales fell 4.3% (volume +5.4%, price-mix -9.7%); Liqueurs & Spirits rose 3.7% (volume +5.7%, price-mix -2.1%).
Currency impact on nine-month sales was -€37 million or -4.7%.
Partner Brands nine-month sales: €12.0 million, down 26.3% organic year-over-year.
Outlook and guidance
Full-year organic sales expected to be stable to up low single digits; operating profit (COP) to decline low double to mid-teens.
Currency effects expected to reduce turnover by €50–60 million and COP by €25–30 million.
Net tariff impact estimated at €25 million, mainly in the U.S. and China.
Guidance factors in continued investment in China and the U.S.
Latest events from Rémy Cointreau
- Q1 sales dropped 15.6% organically, with gradual recovery and cost controls underway.RMC
Q1 24/25 TU3 Feb 2026 - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/241 Feb 2026 - H1 sales dropped 15.9% organically, triggering revised guidance and a major cost-cutting plan.RMC
H1 24/25 TU18 Jan 2026 - Sales and profit dropped, but margins held up due to aggressive cost controls.RMC
H1 24/2512 Jan 2026 - Q3 sales fell 21.5% organically; full-year decline near 18% with margin guidance held.RMC
Q3 24/25 TU9 Jan 2026 - Sales fell 18% organically; margin guidance held, cost savings and tariff risks remain.RMC
Q4 24/25 TU29 Nov 2025 - Sales and profit declined, but transformation and investment in recovery continue.RMC
H1 25/2627 Nov 2025 - Sales and profit fell sharply, but cost savings and a US rebound support cautious optimism.RMC
H2 24/2521 Nov 2025 - H1 sales dropped 4.2% organically, prompting a guidance cut amid China and currency headwinds.RMC
Q2 25/26 TU31 Oct 2025